Download PDF
Nuklearmedizin 2020; 59(02): 85-86
DOI: 10.1055/a-1108-1275
Case Report

Atypical metastatic pattern of prostate cancer detected with 68Ga-PSMA PET/CT

Viktor Fech
  Nuclear Medicine, Inselspital University Hospital Bern, Switzerland
,
Christos Sachpekidis
  Nuclear Medicine, Inselspital University Hospital Bern, Switzerland
,
Ian Alberts
  Nuclear Medicine, Inselspital University Hospital Bern, Switzerland
,
Axel Rominger
  Nuclear Medicine, Inselspital University Hospital Bern, Switzerland
,
Ali Afshar-Oromieh
  Nuclear Medicine, Inselspital University Hospital Bern, Switzerland
› Author Affiliations
› Further Information
    Permissions and Reprints

Introduction

PSMA-ligand PET/CT is a promising imaging modality for prostate cancer (PC), and has rapidly established itself as the modality of choice in the re-staging of biochemical recurrence. Nevertheless, in recent years an increasing number of case reports have been published describing incidental and non-prostatic lesions of both benign and malignant origin, which exhibit high PSMA radiotracer uptake [1]. This frequently leads to confusion in the assessment of PSMA-positive lesions that are not located within typical metastatic sites of PC.

The present case demonstrates that PC metastases should be considered even in non-classical patterns, owing to the high positive predictive value of PSMA-ligand-imaging [2]. The patient benefited from accurate staging of his disease, resulting in an early change in his management.



Publication History

Article published online:
18 March 2020

© Georg Thieme Verlag KG
Stuttgart · New York

 

  • References

  • 1 Sheikhbahaei S, Afshar-Oromieh A, Eiber M. et al. Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging. Eur J Nucl Med Mol Imaging 2017; 44: 2117-2136
    CrossrefPubMedGoogle Scholar
  • 2 Afshar-Oromieh A, Holland-Letz T, Giesel FL. et al Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients. Eur J Nucl Med Mol Imaging 2017; 44: 1258-1268 . https://doi.org/10.1007/s00259-017-3711-7
    CrossrefPubMedGoogle Scholar
  • 3 Afshar-Oromieh A, Sattler LP, Steiger K. et al. Tracer uptake in mediastinal and paraaortal thoracic lymph nodes as a potential pitfall in image interpretation of PSMA ligand PET/CT. Eur J Nucl Med Mol Imaging 2018; 45: 1179-1187
    CrossrefPubMedGoogle Scholar
  • 4 Pyka T, Weirich G, Einspieler I. et al. 68Ga-PSMA-HBED-CC PET for Differential Diagnosis of Suggestive Lung Lesions in Patients with Prostate Cancer. J Nucl Med 2016; 57: 367-371
    CrossrefPubMedGoogle Scholar
  • 5 Vinjamoori AH, Jagannathan JP, Shinagare AB. et al. Atypical metastases from prostate cancer: 10-year experience at a single institution. Am J Roentgenol 2012; 199: 367-372
    CrossrefPubMedGoogle Scholar